Olusoji Adeyi, BSc, MD, MCommH, MBA, DrPH, is the President of Resilient Health Systems in Washington DC and a Senior Associate at the Johns Hopkins Bloomberg School of Public Health in Baltimore, USA. He is the author of the critically acclaimed book, “Global Health in Practice: Investing Amidst Pandemics, Denial of Evidence, and Neo-dependency.” 

Dr. Adeyi has had a distinguished career in global health and development, with professional and leadership positions at the World Bank, World Health Organization, UNAIDS, and Global Fund to Fight AIDS, Tuberculosis, and Malaria. In his career at the World Bank, Dr. Adeyi served as Director of the Health, Nutrition, and Population Global Practice, and Senior Advisor for Human Development, among other leadership responsibilities across the world. He was the founding Director of the Affordable Medicines Facility for malaria (AMFm) at the Global Fund. He has led initiatives on global and regional health policies, strategies, and programs; authored many papers and books on health policy and systems; and co-led multiple partnerships and commissions in health. Dr. Adeyi serves on several global health commissions and high-level advisory groups.

Professor Deborah Ashby is Dean of the Faculty of Medicine at Imperial College London where she holds the Chair in Medical Statistics and Clinical Trials. She was previously Director of the School of Public Health and was Founding Co-Director of Imperial Clinical Trials Unit. Prior to that, she held the Chair in Medical Statistics at Barts and the London School of Medicine and Dentistry, Queen Mary University of London and academic appointments at the University of Liverpool Her research interests are in clinical trials, risk-benefit decision making for medicines, and the utility of Bayesian approaches in these areas.

She sat on the UK Commission on Human Medicines for many years and also acted as adviser to the European Medicines Agency.  She has chaired the Population Research Committee for Cancer Research UK and the National Institute for Health Research (NIHR) HTA Commissioning Board and was Deputy Chair of the HTA Programme.

She is a Chartered Statistician and Honorary Member of both the Royal College of Radiologists and the Faculty of Public Health Medicine. She was awarded the OBE for services to medicine in 2009, appointed an NIHR Senior Investigator in 2010, elected to the Academy of Medical Sciences in 2012 and was President of the Royal Statistical Society for 2019 and 2020.

Dr. Natasha Bagdasarian is the Chief Medical Executive for the State of Michigan. In this role she provides strategic public health guidance for on a multitude of public health issues including communicable diseases, chronic illnesses, environmental and reproductive health.

She is board certified in Internal Medicine and Infectious Diseases.  She is a Fellow of the Infectious Diseases Society of America and the American College of Physicians.

Dr. Eduardo P. Banzon is Director of the Health Practice Team at the Asian Development Bank (ADB), where he leads initiatives advancing universal health coverage (UHC) and regional health policy. Known as “Doc Dodo,” he collaborates across sectors to design and implement strategies that reduce poverty and strengthen human capital in Asia and the Pacific. Since November 2021, he has also served as an Honorary Affiliate at the Saw Swee Hock School of Public Health, National University of Singapore, contributing expertise in health financing, policy, and global health collaboration. With over 34 years of experience, he has held senior roles including President and Chief Executive Officer of Philippine Health Insurance Corporation (PhilHealth) and Regional Adviser for Health Economics and Health Financing at the World Health Organization Eastern Mediterranean Regional Office. Dr. Banzon holds degrees in Biology, Medicine from the University of the Philippines College of Medicine, and a Master of Science in Health Policy, Planning, and Financing jointly awarded by the London School of Economics and Political Science and the London School of Hygiene and Tropical Medicine.

‍

Professor Otavio Berwanger is Executive Director for The George Institute for Global Health, UK and Chair in Clinical Trials at Imperial College London. An esteemed cardiologist and clinical trialist, Otavio has extensive research and managerial experience and has led large-scale, global randomised clinical trials. Studies led by Otavio have been published in high-impact journals such as the New England Journal of Medicine, The Lancet, JAMA and BMJ. In his capacity as Executive Director he leads the Institute’s work in partnership with Imperial College London, with its core focus on large-scale clinical trials, health systems science, multimorbidity, and women’s health.  He will also build on his personal research interests in exploring innovative and efficient patient-centric clinical trial models.

Thomas J. Bollyky is the inaugural Bloomberg Chair in Global Health at the Council on Foreign Relations where he directs the global health program. He is also CFR’s senior fellow in international economics, law, and development and a senior consultant to the Coalition for Epidemic Preparedness Innovations. Mr. Bollyky is the author of the book Plagues and the Paradox of Progress: Why the World Is Getting Healthier in Worrisome Ways and the founding editor of Think Global Health, an online magazine that examines the ways health shapes economies, societies, and everyday lives around the world. He directed the first two CFR-sponsored Independent Task Forces devoted to global health: Improving Pandemic Preparedness: Lessons from COVID-19 (2020) and The Emerging Global Health Crisis: Noncommunicable Diseases in Low- and Middle-Income Countries (2014). Prior to coming to CFR, Bollyky served in a variety of positions in the U.S. government, most recently at the Office of the U.S. Trade Representative (USTR). Mr. Bollyky has testified multiple times before the U.S. Congress, and his work has appeared in a wide range of general interest publications, such as the Atlantic and New York Times, and scholarly journals, such as Science, Nature, and the New England Journal of Medicine. He has also served as a consultant to the Bill and Melinda Gates Foundation and as a temporary legal advisor to the World Health Organization. In 2013, the World Economic Forum named Mr. Bollyky as one of its global leaders under forty. Mr. Bollyky received a BA in biology and history from Columbia University and a JD from Stanford Law School.

Francesca Colombo, M.Sc., is Head of the Health Division at the Organisation for Economic Co-operation and Development. In this capacity, she leads OECD work on health, which aims at providing internationally comparable data on health and health systems and applying economic analysis to health policies, advising policy makers, stakeholders and citizens on how to respond to demands for more and better health care and make health systems more resilient and people centred. Major activities under her responsibility cover solutions to make health systems more resilient, including health workforce and the financial sustainability of health systems; measuring of health systems, including the OECD Patient Reported Indicators Survey initiative and trends in health spending; healthcare quality policies; megatrends, including ageing, climate change and health, digital health and Artificial Intelligence; the economics of public health; and pharmaceutical policies and medical supply chains (http://www.oecd.org/health). Ms Colombo serves as a member of the Lancet Pandemic Readiness, Implementation, Monitoring and Evaluation Commission on COVID-19, the board the Board of Advisers for the Lancet Global Health Commission on People-Centered Care for Universal health Coverage, the World Health Summit Council, the French government’s Commission des comptes de la santé, and was co-chair of the World Economic Forum Global Future Council on Health and Healthcare, and other international advisory boards. Ms Colombo has over 25 years of experience leading international activities on health and health systems. Over her career, she advised governments across a spectrum of countries on health system policies and reforms.

Dr Alex Cook is a Professor in the Saw Swee Hock School of Public Health at the National University of Singapore (NUS), where he is also the Vice Dean of Global Health. He was the founding director of the Centre for Epidemic Research and Modelling. His work uses quantitative methods such as infectious disease modelling and statistics to address public health problems, including dengue, COVID-19, influenza, diabetes and tobacco control. His multidisciplinary team brings together researchers from the fields of statistics, computational biology, computer engineering, mathematics, geography and environmental sciences.

Research by the Cook lab is often in close collaboration with government agencies. Examples of the contribution of his work to national policy making include: 

1. His team’s projections of the future burden of diabetes in Singapore was cited in the Committee of Supply as the Minister of Health declared ‘war’ on diabetes; 
2. His team’s work during the COVID-19 pandemic provided information to support government decisions in reopening society, border measures, and vaccination;
3. His close collaboration with the National Environment Agency has led to the development of a realtime dengue forecasting algorithm that is routinely used as part of Singapore’s vector control programme.

Eivind Engebretsen is Professor of Interdisciplinary Health Science and a medical humanities scholar at the University of Oslo, where he heads the Centre for Sustainable Healthcare Education, a national Centre of Excellence in Education. He is also Dean of Circle U., a European university alliance of nine universities. His research explores how medical knowledge is translated across cultural and institutional contexts, with a particular focus on trust and public compliance. As a contributor to the NUS–Lancet PRIME Commission, he has helped develop grassroots indicators that ground assessments of pandemic readiness in people’s everyday experiences.

Sakiko Fukuda-Parr is Professor Emerita of International Affairs at The New School, President of the International Association for Feminist Economics, and co-coordinator of the Collective on the Political Determinants of Health at the University of Oslo. She is also Senior Fellow of the New School’s India China Institute and Non-Resident Fellow of the Heilbroner Center for Capitalism Studies.  Her current research focuses on global economic governance for equity and justice, including decolonizing international affairs, critical global health, gender and worker rights, the politics of global goal setting and governance by indicators. She has published widely on a broad range of topics including inequality, poverty, international economic governance, gender and technology.  Her co-authored book, Fulfilling Social and Economic Rights (with T. Lawson-Remer and S. Randolph), received the Grawemeyer Prize for Ideas to Improve the World Order. 

From 1995 to 2004, Fukuda-Parr was lead author and director of the UNDP Human Development Reports.  She was appointed by the UN Secretary General to the UN Committee on Development Policy (2012-24), and the UN High Level Panel on Access to Medicines on Innovation (2016). 

Her most recent publication, Palgrave Handbook on Decolonizing International Affairs, co-edited with Sean Jacobs, is scheduled for release in July 2026.

Proffessor Alberto Garcia-Basteiro is Research Professor at the Barcelona Institute for Global Health, ISGlobal, Head of Department of Preventive Medicine and Epidemiology at Clinic-Barcelona Hospital, in Spain, and Coordinator of the TB research unit at the Centro de Investigação em Saúde de Manhiça (CISM), Mozambique. 

He has over 15 years of experience in global health, having lived and worked in Central America and Southern Africa, with a focus on strengthening research capacity and conducting research in vulnerable populations affected by poverty-related diseases.

Currently, he coordinates several large observational studies, diagnostic evaluations and drug clinical trials in the field of tuberculosis, with a focus in sub-Saharan Africa. His research interests include the study of the burden of vaccine preventable diseases in different vulnerable populations and characterization of the infectious diseases at multiple levels including clinical, microbiological and social. He has published over 250 manuscripts in peer-reviewed biomedical journals.

He has received several awards including, the Young Investigator Prize ( The Union against TB and Lung Disease), Early Career Member Award (The European Respiratory Society (ERS)), the Stephen Lawn TB-HIV Research Leadership Prize (the LSHTM, the Desmond Tutu HIV Centre at UCT, and The Union).

‍

David Heymann is a medical epidemiologist and Professor of Infectious Disease Epidemiology at the London School of Hygiene and Tropical Medicine. From 2009 to 2017 he was chair of the UK Health Protection Agency and then Public Health England, and during this period he also led the Centre on Global Health Security at Chatham House (London). From 1989 to 2009 Heymann held various leadership positions in infectious diseases at WHO, and in 2003 headed the WHO global response to SARS in his role as executive director of communicable diseases. In 1976, after spending two years working in India on smallpox eradication, Heymann was a member of the CDC (Atlanta) team to investigate the first Ebola outbreak in DRC and stayed on in sub-Saharan Africa for 13 years in various field research positions on Ebola, monkeypox, Lassa Fever, malaria and other tropical diseases. Heymann has published over 275 peer reviewed articles and book chapters, is editor of the Control of Communicable Diseases Manual, and is an elected member of the UK Academy of Medical Sciences and the US National Academy of Medicine. In 2009 he was named an Honorary Commander of the Most Excellent Order of the British Empire for services to global health.

Dr Hsu Li Yang is a Singapore-based infectious diseases physician and public health scholar. He is Professor at the Saw Swee Hock School of Public Health, National University of Singapore (NUS), and Director of the Asia Centre for Health Security. Over more than twenty-five years, his work has bridged clinical medicine, genomic research, and population health, with a focus on Singapore, ASEAN, and the wider Asia-Pacific.

His research spans antimicrobial resistance, healthcare-associated infections, tuberculosis, pathogen genomics, and outbreak response, comprising over 200 peer-reviewed publications and more than S$40 million in research grants. He has served on numerous national and international advisory bodies, including several WHO technical and verification groups, and was awarded Singapore's Public Administration Medal (Bronze) in 2023.

Committed to public engagement, he has co-authored popular graphic works on antibiotics and pandemics, and has served as President of the Singapore Chess Federation since 2021.

Professor Michel Kazatchkine has over 35 years of experience in global health as a leading physician, researcher, administrator, advocate, policymaker, and diplomat. He attended medical school in Paris and completed postdoctoral fellowships at St. Mary’s hospital in London and Harvard Medical School. He is Emeritus Professor of Immunology at René Descartes University in Paris.

Professor Kazatchkine has played key roles in various organizations, serving as Director of the national Agency for Research on AIDS in France and French ambassador on Global health. In 2007, Professor Kazatchkine was elected Executive Director of the Global Fund to fight AIDS, Tuberculosis and Malaria, a position in which he served until March 2012. Between 2012 and 2020, Professor Kazatchkine served as the UN Secretary General Special Envoy on HIV/AIDS in Eastern Europe and Central Asia and Special Advisor to the Joint UN Program on HIV/AIDS (UNAIDS).  

He is currently a Senior Fellow with the Global Health Centre of the Graduate Institute for International and Development Studies in Geneva (https://graduateinstitute.ch), a member of the Global Commission on Drug Policy (https://globalcommissionondrugs) and a Senior advisor to the Regional Director for Europe of the World Health Organization.

Professor Kazatchkine has recently served as a member of the Independent panel on Pandemic Preparedness and Response (https://theindependentpanel) and as a distinguished Fellow at the Institute of Global Politics (IGP), SIPA, Columbia University.

Professor Kazatchkine holds Honorary Degrees from Imperial College, London, the Free University of Brussels, the Catholic University of Louvain and the University of Geneva. He is an Officer of the Légion d’Honneur in France and the recipient of several other national Orders and national/ international awards.

‍

Kelley Lee is Professor and Tier 1 Canada Research Chair in Global Health Governance in the Faculty of Health Sciences, Simon Fraser University.  She was formerly Head of Department at the London School of Hygiene and Tropical Medicine and Co-Director of the WHO Collaborating Centre on Global Change and Health.  Her research focuses on collective action to manage transboundary health risks including major infectious disease outbreaks.  As Principal Investigator of the Global Tobacco Control Research Program (2002-2018), she led efforts with colleagues to secure millions of pages of tobacco industry documents of British American Tobacco, and conducted extensive analyses of the industry’s globalization strategies.  Her current projects focus on strengthening pandemic prevention, preparedness, response and recovery.  She leads the Pandemics and Borders Project on the effective use of travel measures during public health emergencies, and the Bridge Research Consortium to support optimal uptake of new vaccines and immunotherapies as part of Canada’s Biomanufacturing and Life Sciences Strategy.  She currently serves on the WHO Editorial Board for the Global Reportonthe Economic and Commercial Determinants of Health.  She co-chaired the forthcoming Royal Society of Canada-Canadian Academy of Health Sciences Expert Panel Report on Canada’s role in global health.  She has published 15 books, 250+ papers and 60+ book chapters including co-editing the Oxford Handbook of Global Health Politics (OUP, 2020). She is a Fellow of the UK Faculty of Public Health, Canadian Academy of Health Sciences, and Royal Society of Canada.

Professor Vernon Lee is a preventive medicine physician with extensive global health experience in pandemic preparedness and response, infectious disease epidemiology and health policy and management. He played an instrumental role in developing and implementing Singapore’s COVID-19 pandemic response, and has also responded to the 2003 SARS outbreak, 2009 influenza pandemic, and the 2016 Zika outbreak in Singapore.

Prof Lee previously served as Advisor to the Assistant Director General for Health, Security and Environment at the WHO headquarters in Geneva; Medical Epidemiologist in the WHO’s Country Office in Indonesia; and Head of the Biodefence Centre in the Singapore Armed Forces. Through his work, Prof Lee has been involved in major global health security collaborations, and in developing pandemic preparedness plans, risk assessment and disease management programmes. He continues to serve on expert committees at the international level.

An avid supporter of evidence-based health policy, Prof Lee has published about 200 scientific papers, many in top journals, including the New England Journal of Medicine (NEJM), Journal of the American Medical Association (JAMA), and the Lancet journals. He is an Adjunct Professor at the Singapore’s Saw Swee Hock School of Public Health.

Prof Lee graduated from medical school at the National University of Singapore. He also holds a PhD in epidemiology from the Australian National University, and the Master in Public Health and Master of Business Administration degrees from the Johns Hopkins University, USA.

‍

Leo Yee Sin served as the inaugural Executive Director of the National Centre for Infectious Diseases (NCID), Singapore from 2017 to 2023. She is currently the Senior Advisor to NCID and holds concurrent faculty appointments with Saw Swee Hock School of Public Health at National University of Singapore and Lee Kong Chien School of Medicine at Nanyang Technological University.

As an adult Infectious Diseases specialist, Prof Leo has led her team through multiple outbreaks in Singapore. These include Nipah in 1999, SARS in 2003, the pandemic influenza in 2009, Zika in 2016, multiple surges of Dengue epidemic and in the recent years, she was a pivotal figure during the COVID-19 pandemic.

Prof Leo has published more than 400 peer-reviewed scientific papers. Her experience and expertise in outbreak management is frequently called upon as advisor and conference speaker at the national, regional and international level. She currently serves as technical advisor to the World Bank Pandemic Fund and numerous technical and strategic workgroups with the World Health Organization.

She has won numerous awards including National Day Public Service Star Awards in recognition for her outstanding battle against SARS in 2023 and COVID-19 in 2021. She was recognised as the BBC 100 Women 2020 and was conferred the title of Knight of the French Order of the Legion of Honour in 2022. Her extensive experiences in outbreak management make her well-poised in her role as commissioner to the NUS-Lancet Commission Series.

Gabriel Leung is known for his commitment to improving human capabilities, nurturing impactful innovation and building strong institutions. He is Executive Director (Charities and Community) of The Hong Kong Jockey Club overseeing its Charities Trust, while serving as a governor of The Wellcome Trust – both of which are amongst the largest and most impactful philanthropies globally.

Gabriel’s career has straddled academe, public service and philanthropy. From 2013 to 2022, he was the longest-serving Dean of Medicine and inaugural Helen and Francis Zimmern Professor in Population Health at the University of Hong Kong (HKU). Formerly, he was Hong Kong's first Under Secretary for Food and Health and fifth Director of the Chief Executive's Office in government.

Gabriel’s research defined the epidemiology of three novel viral epidemics, namely SARS in 2003, H7N9 influenza in 2013 and most recently COVID-19. In government, he led Hong Kong's response against the 2009 influenza pandemic. He was founding co-director of HKU's World Health Organization (WHO) Collaborating Centre for Infectious Disease Epidemiology and Control and established the Laboratory of Data Discovery for Health (D24H) at the Hong Kong Science and Technology Park.

Gabriel is a member of the US National Academy of Medicine. He is currently serving as a member of WHO’s Strategic Advisory Group of Experts on Immunization (SAGE).

Dr. Liu, a veteran humanitarian aid worker, is a Canadian practicing paediatric emergency physician at University of Montreal and professor at McGill University’s School of Population & Global Health where she focuses on pandemic and health emergencies at the Pandemics and Health Emergency Readiness Lab (PERL). Prior to joining McGill, Dr. Liu began her career with Médecins Sans Frontières/Doctors Without Borders (MSF) in 1996 and went on to serve as the International President of MSF for over six years from 2013-2019.  Through her leadership, she spearheaded the emergency responses to humanitarian and health emergencies including outbreaks/epidemics in West (Ebola 2014-2016) and Central Africa, Middle East, Central Asia, South East Asia, Caribbean & Central America. She was a leading voice in condemning attacks on medical mission which led to the UNSC resolution 2286. 

Dr. Liu graduated from the McGill University School of Medicine in Montreal in 1991 and did her pediatric specialty training at University of Montreal. She holds a Fellowship in Paediatric Emergency Medicine from New York University School of Medicine as well as an International Master’s in Health Leadership, also from McGill University. She is the chair of the Humanitarian Dialogue Center.

Sitong Luo, PhD, Associate Professor of Behavioural and Implementation Sciences at Vanke School of Public Health, Tsinghua University, China, and Member of the WHO's Technical Advisory Group on Behavioural Sciences for Better Health. Her research focuses on behavioural perspectives in the fight against infectious diseases (e.g., HIV/AIDS, emerging infectious diseases, vaccine hesitancy) and also conduct research on implementation and evaluation of health policies. She works closely with international organizations (e.g., WHO, UNAIDS) and serves as a technical advisor for several governmental agencies. She has published over 70 peer-reviewed papers in leading journals and was awarded the Early Career Award by the International Society of Behavioural Medicine in 2021.

Dr Yodi Mahendradhata is Dean and Professor in Health Policy and Management at the Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Indonesia. He leads the South-East Asia Regional Training Center for Health Research, supported by the Special Programme for Research and Training in Tropical Diseases (TDR). Dr Mahendradhata chairs the Research Committee of the Consortium of Universities for Global Health (CUGH). He serves in the Steering Committee of the Alliance of Academic Health Centers International (AAHCI) Steering Committee and the Governing Board of the Southeast Asian Ministers of Education Organization Tropical Medicine and Public Health Network (SEAMEO TROPMED). He is also Scientific Advisory Board member of the Institute of Tropical Medicine, Antwerp, Belgium and Partnership Advisory Council member of the Department of International Health, Johns Hopkins University Bloomberg School of Public Health and member of the BMJ Asia Pacific Regional Advisory Board. 

Professor J. Jaime Miranda, MD, MSc, PhD, FFPH, is Professor and Head of School of the Sydney School of Public Health at the University of Sydney. Before joining Sydney, he was a Full Professor at Universidad Peruana Cayetano Heredia (UPCH) in Lima, Peru, where he founded the CRONICAS Center of Excellence in Chronic Diseases. Professor Miranda’s research focuses on chronic non-communicable diseases (NCDs) in low- and middle-income countries, especially obesity, hypertension, diabetes, and mental health.

Professor Miranda has held notable leadership roles, including Councillor for Latin America and the Caribbean at the International Epidemiological Association (2011-2014), Co-Chair of the Global Alliance for Chronic Diseases Steering Committee (2012-2016), and President of the Advisory Committee on Health Research for the Pan American Health Organization (2014-2016). A Fellow of the Faculty of Public Health of the Royal College of Physicians, he was recognized as one of the top 30 scientists under 40 in Latin America in 2014.

Currently, Professor Miranda serves on the WHO Scientific and Technical Advisory Committee for Health Policy and Systems Research (2021-24), WHO’s Technical Advisory Group of Experts on NCD-related Research (2021-25), and as Co-Chair of the UN Independent Group of Scientists drafting the 2023 Global Sustainable Development Report. Professor Miranda trained in medicine at UPCH and earned his PhD in epidemiology from the London School of Hygiene and Tropical Medicine. He is also affiliated with the Harvard T.H. Chan School of Public Health, the George Institute, and the London School of Hygiene and Tropical Medicine.

Prof Francisca Mutapi is a global health expert empowering African scientists and policymakers to tackle infectious diseases and improve epidemic preparedness prioritising local needs and solutions. She holds a Chair in Global Health infection and Immunity at the University of Edinburgh where she is the Deputy Director of the TIBA (Tackling Infections to Benefit Africa) Partnership. She has collaborated on genomic research detailing the multiple separate introductions of SARS-CoV-2 infections into Africa, epidemiology studies identifying the predictors of COVID-19 epidemics in WHO AFRO countries, and immuno-epidemiological work identifying SARS-CoV-2 cross-reactive immune responses in historical samples collected from African populations. Her COVID19 work also informed PPE provision to health workers and medical oxygen production in Zimbabwe. Her evidence synthesis and policy work is contributing to national and global pandemic preparedness plans. She is helping shape global health research and training directly through her own research, as a thought leader and through independent advisory board membership. She sits on various funding committees and technical/strategic advisory boards including the WHO Africa Regional Director’s Advisory Board, the UK Government’s Foreign, Commonwealth & Development Office Science Advisory Group and is the vice board chair of Uniting to Combat Neglected Tropical Diseases. She chairs the WHO AFRO Vaccine Effectiveness Monitoring network (AFRO-MOVE)’s strategic advisory group, and is a member of the WHO Steering Group developing a blueprint for NTD research and development as well as African Union (AU) working group developing a costed roadmap for the AU’s domestic health financing strategic plan.

Professor Ivy Ng is Senior Advisor, SingHealth Board.  Prior to her appointment as Senior Advisor, she was the Group Chief Executive Officer of SingHealth (2012-2024).  She was also previously Chief Executive Officer of KK Women's & Children's Hospital (KKH) and Deputy Group Chief Executive Officer of SingHealth.  

SingHealth is Singapore’s largest healthcare group and comprises Singapore General Hospital, KK Women’s and Children’s Hospital, Changi General Hospital, Sengkang General Hospital, 5 National Specialty Centres (Cancer, Eye, Neurosciences, Dental and Heart), SingHealth Community Hospitals and 9 primary health polyclinics. SingHealth has also been charged to develop Eastern General Hospital.

She was conferred the National Day Award Public Administration Medal (Gold) (Bar) 2024, President’s Science & Technology Medal 2021, National University of Singapore (NUS) University Outstanding Service Award 2020.  She is Chair of the KKH Fund Committee and member of the Boards of SingHealth Fund, Duke-NUS Medical School, Singapore Management University, Temasek Trust, National Research Foundation (NRF) Singapore and Precise Health Research Singapore (PRECISE) Board Oversight Committee (BOC).

She holds a Bachelor of Medicine, Bachelor of Surgery (MBBS) and Master of Medicine (Paediatrics) from the National University of Singapore. She is a Fellow of the Royal College of Physicians (FRCP, Edinburgh), Royal College of Paediatrics and Child Health (FRCPCH, London) and Academy of Medicine, Singapore (FAMS). She is Clinical Professor, Duke-NUS Medical School and Yong Loo Lin School of Medicine, National University of Singapore and Adjunct Professor, Saw Swee Hock School of Public Health, National University of Singapore.

Anders Nordström is the former Swedish Ambassador for Global Health. Medical doctor by background from the Karolinska Institute. 

Today advisor associated with the Karolinska Institute and the Stockholm School of Economics.

He is currently a member of the Alliance for Health Systems Research’s board, the SUN-Lancet PRIME Commission, the International Vaccine Institute Global Advisory Group of Experts, and the Virchow Foundation for Global Health Council.

Recently he headed the Secretariat for the Independent Panel for Pandemic Preparedness and Response (2020-21).  

He served as Acting Director-General for WHO  (May 2006 – January 2007) and as Assistant Director General for General Management (2003-2006), Assistant Director General for Health Systems and Services (2007) and Head of the WHO Country Office in Sierra Leone (2015-17). 

As the Interim Executive Director, he established the Global Fund to Fight AIDS, Tuberculosis and Malaria as a legal entity in 2002.  

He has previously served as board member of the Global Fund to fight AIDS, TB and Malaria, GAVI, UNAIDS and PMNCH and chaired a number of international working groups and processes. 

He was the Director-General for the Swedish International Agency for Development Cooperation (2007-2010).

Robyn Norton is the Founding Director of The George Institute for Global Health, a not-for-profit, medical research organisation established in Sydney, Australia in 1999 and now also with offices in China, India, and the UK.  Robyn is Professor of Public Health at the University of New South Wales (UNSW), Sydney and Emeritus Professor of Global Health at Imperial College London. She has published widely in the fields of injury, global health, and women’s health.  

Robyn has had a longstanding commitment to improving the health of women and girls and co-established The George Institute’s Global Women’s Health Program in 2018 and more recently the Centre for Sex and Gender Equity in Health and Medicine, a partnership with the Australian Human Rights Institute at UNSW and Deakin University, Melbourne.  Robyn leads the Centre’s Working Group aimed at engaging with the business sector to ensure that research findings are translated into new and better commercial innovations in the pharmaceutical and medical device industries.  She is also co-principal investigator on the MESSAGE (Medical Science Sex and Gender Equity) project which aims to create policies ensuring biomedical, health and care researchers in the UK consider both sex and gender in their work. 

Robyn was appointed a Fellow of the Australian Academy of Health and Medical Sciences in 2016 and was made an Officer (AO) in the General Division of the Order of Australia in 2017. In 2023, she was appointed to the Australian Women’s Health Advisory Council.

Dr. Ebere Okereke is a global health physician, whose work primarily focuses on health security, health system strengthening, and the cultivation of effective leadership in the field. Dr Okereke has garnered prestigious accolades in recognition of her advocacy for women and under-represented groups in public health leadership. 

She was recognised as an outstanding role model for women in academic medicine by the British Medical Association in 2022 and was profiled in The Lancet in November 2023, and in December 2023 she received an honorary Doctor of Science degree from the Liverpool School of Tropical Medicine UK. 

Dr Okereke is a Fellow of the UK Faculty of Public Health and an Associate Fellow at Chatham House. She is a graduate of the University of Nigeria College of Medicine and has post graduate and executive level qualifications from Newcastle University, Liverpool School of Tropical Medicine and the London School of Hygiene and Tropical Medicine

Dr Okereke serves on the WHO Africa Region’s Emergency Preparedness and Response Technical Advisory Group; the Steering Committee of the Africa CDC Kofi Annan Global Health Leadership Programme, and on many other boards and advisory groups for organisations committed to strengthening public health systems and promoting equity. She is currently the Chief Program Office at Reaching the Last Mile, the private philanthropic foundation of the President of UAE.

Professor David Peiris leads the development and implementation of the institute’s research strategy and is a Professor in the Faculty of Medicine at UNSW Sydney. He also works as a locum GP with Miwatj Health in Galiwin’ku, Elcho Island. His work focuses on strengthening primary health care globally, particularly improving access to affordable, high-quality services. His research spans health systems science, including health policy, health services research, and implementation science. David has published extensively and leads several grants testing innovative strategies to improve access to high-quality primary health care.

Dr. Pablo Perel, originally from Argentina, is a Professor of Clinical Epidemiology at the London School of Hygiene & Tropical Medicine and serves as a Senior Science Advisor for the World Heart Federation. 

His work focuses on developing and evaluating innovative approaches to manage noncommunicable diseases (NCDs) in limited resources settings; including humanitarian and conflict settings where health systems are frequently disrupted.

In addition to his academic and editorial roles, Dr. Perel is actively engaged in international organizations, serving in leadership positions at the Global Alliance for Chronic Diseases, the Foundation for Innovative Diagnostics, and the Medicine Patent Pools. He is a member of several scientific advisory committees and technical groups, where he helps guide research and policy decisions in the field of global cardiovascular diseases.

As a member of the NUS-Lancet Pandemic Readiness, Implementation, Monitoring, and Evaluation (PRIME) Commission, Dr. Perel will contribute his expertise to ensure that pandemic preparedness frameworks do not neglect the care of people living with NCDs. 

His contribution will underscore the importance of resilient health systems that can continue to support people with chronic conditions during crises, advancing the Commission’s goal of a comprehensive and inclusive approach.

Dr. Karina Rando is a physician anaesthesiologist, academic professor, and public health leader with extensive experience at the intersection of clinical medicine, health systems, and global health. She currently serves as Dean of the Faculty of Health Sciences at Universidad de la Empresa (UDE), Uruguay, where she leads academic development and postgraduate training in public health and health sciences .

She previously held the position of Minister of Public Health of Uruguay (2023–2025), following her role as Director General of Coordination at the Ministry of Public Health (2020–2023), where she played a central role in the national response to the COVID-19 pandemic .

Dr. Rando has a strong academic trajectory spanning more than two decades at the University of the Republic (UDELAR), where she served as Assistant, Adjunct and Associate Professor in anaesthesiology and pathophysiology, contributing to teaching, research, and the training of health professionals . She was also a Level I Researcher in Uruguay’s National System of Researchers and has authored nearly 50 peer-reviewed publications in clinical medicine, patient safety, and public health.

She completed her medical degree at UDELAR, followed by specialist training in Anaesthesiology at the Hospital de Clínicas. She later obtained a Master of Science in Public Health from the London School of Hygiene and Tropical Medicine, University of London, and completed a doctoral thesis in medicine focused on cost-effectiveness in perioperative care for liver transplantation .

Her clinical career is anchored in high-complexity anaesthesia. She has been a member of the Bi-institutional Liver Transplant Unit since 2009 and previously served as Head of the Anaesthesiology Service at the Central Hospital of the Armed Forces. In parallel, she has contributed to international surgical cooperation as a volunteer anaesthesiologist with ReSurge International since 2007.

Her work integrates academic leadership, high-level policymaking, and clinical excellence, with a particular focus on health system strengthening, equity, and capacity building in resource-constrained settings.

‍

Andrea Renda is Director of Research at the Centre for European Policy Studies (CEPS). At CEPS he also leads the research team on Global Governance, Regulation, Innovation and the Digital Economy. He is Adjunct Professor of Digital Policy at the School of Transnational Governance of the European University Institute, in Florence (Italy), where he teaches “Regulation of Emerging Technologies” and is involved in several executive training courses on topics such as strategic foresight, AI bias, high-quality regulation and agile governance. Andrea is Visiting Professor of AI Policy, Ethics and Governance at the College of Europe in Bruges (Belgium). He is a Fellow of the World Academy of Arts and Science, and a CITI Fellow at Columbia University. He is currently the Vice Chair of the advisory group on Economic and Societal Impacts of Research (ESIR), for the European Commission, DG Research and Innovation; and member of the Expert Group on “Fair and Sustainable Economy” at the European Commission, DG Joint Research Centre. He was a Distinguished Fellow appointed to provide advice to the European Commission, DG GROW for the year 2023. He is the Co-director of the Brookings/CEPS Forum for Global Cooperation on AI. He is also a member of the OECD Network of Experts on AI, where he is currently the Co-Chair of the Working Group on AI Risk and Accountability. He also Chairs the AI Committee of the Italian telecommunications and media regulator, AGCOM; and is member of the board at the Energy Policy Group in Sofia (Bulgaria), and of the Global Policy Centre of the Instituto de Empresa in Madrid (Spain). He is a non-executive board member of Canonical, the company producing Ubuntu, a widely used open sources operating system (through to January 2028).

Tomoya Saito, MD, MPH, PhD Tomoya Saito, MD, MPH, PhD is a public health crisis management expert specializing in the interface between health and security, Dr. Saito has over two decades of experience managing major public health emergencies — including the Fukushima nuclear accident (2011), emerging infectious diseases (H7N9, MERS, SFTS, Ebola), and the COVID-19 pandemic, during which he served on the MHLW COVID-19 Advisory Board and the national cluster response team.

Dr. Saito serves on expert committees of the Government of Japan and WHO, including IHR Review Committees and Emergency Committees, and has contributed to preparedness for major international events such as the Tokyo 2020 Olympic and Paralympic Games.

He holds his MD from Keio University School of Medicine and previously served as Director of the Department of Health Crisis Management at the National Institute of Public Health and as a medical officer at the Ministry of Health, Labour and Welfare.

Dr Sudhvir Singh is a physician and global health policy leader, currently serving as Special Adviser to the Chair of the Board at Gavi, the Vaccine Alliance. Previously, he was Unit Head for Equity and Health at the World Health Organization, where he led WHO’s global work on the social determinants of health and health equity, including the development and launch of the World Report on Social Determinants of Health Equity. Earlier, he served as Special Adviser and Secretariat Coordinator to the Co-Chairs of the Independent Panel for Pandemic Preparedness and Response, contributing to its work on strengthening national and global systems for pandemic preparedness and response. He previously held director roles at the EAT Foundation, where he helped establish the EAT-Lancet Commission and was a co-author of its landmark report. He trained in medicine at the University of Auckland, holds postgraduate degrees in health policy and economics from the London School of Economics and public policy from the University of Chicago, and is a Fellow (Hon) of the New Zealand College of Public Health Medicine.

Viroj Tangcharoensathien trained in medicine at Siriraj Hospital, Mahidol University. He served 10 years in small rural hospitals in Ubon Ratchatani province at Thai-Lao border. He received the Thai Medical Association’s Best Rural Doctor Award in 1986. His doctoral thesis in Health Financing at London School of Hygiene and Tropical Medicine (LSHTM) won the 1991 Woodruff Medal for the most outstanding thesis. He returned to Thailand in 1991 as health policy analyst at Ministry of Public Health. In 1998, he co-found and was director of International Health Policy Program (IHPP), an arm-length quasi-public research institute affiliated with Ministry of Public Health.  

He received Edwin Chadwick Medal from LSHTM in 2011 for his contributions to improve health systems in the interests of the poor; and the Sam Adjei Distinguished Public Service Award in 2018 by the Alliance for Health Policy and Systems Research and Health Systems Global for his engagement in health systems development and research. He received WHO Director-General’s Health Leaders 2019 Award in recognition of his outstanding leadership in Global Health. His scholarly contributions include 357 international peer-reviewed publications since 1989. In addition, he is the vice chair of the Bureau of the Intergovernmental Negotiating Body since 2022 to draft and negotiate a pandemic agreement until the present. He is also the Member of the National Health Security Board, chair of the Benefit Package sub-committee, member of Central Procurement sub-committee, these works can link relevant researches with policy decision related to UHC.

Professor Teo Yik Ying is Dean of the Saw Swee Hock School of Public Health at the National University of Singapore, and concurrently a Governing Board Member for the Southeast Asian Ministers of Education (SEAMEO) Regional Centre for Tropical Medicine and Public Health Network and a member of the Accra Reset High-Level Panel on Reform of Global Health Architecture and Governance.

Prior to his Deanship, he was the Director for the Centre for Infectious Disease Epidemiology and Research, and Founding Director for the Centre for Health Services and Policy Research for the School of Public Health.

Professor Teo is presently a member of the International Organising Committee for the Prince Mahidol Award Conference, as well as the M8 Alliance which forms the academic foundation for the World Health Summit. He is the Co-Director for the Asia Pacific Academic Consortium for Public Health’s Collaborating Centres for Health Promotion, and sits on the Global Coalition of Deans of Schools of Public Health.

Professor Teo previously worked on the use of genetic technologies for the control and elimination of several infectious diseases, including malaria and tuberculosis. As a previous member of the global MalariaGEN network, he was actively involved in training and capacity development of research fellows from different African and Southeast Asian countries.

He received his BSc in Mathematics from Imperial College in 2000, MSc in Applied Statistics and DPhil in Statistics from the University of Oxford in 2001 and 2006 respectively.

In 2023, Prof Teo was appointed Vice President of NUS’ new Office of Global Health, which is a multidisciplinary whole-of-University effort to drive NUS’ health engagement efforts on the global stage. Besides influencing health and policy outcomes through interdisciplinary translational research, advocacy and analysis, the Office of Global Health will also build on NUS’ strategic partnerships and develop local expertise in global health among neighbouring countries in the region through training and capacity-building.

Professor Maoyi Tian's main research focus on the prevention and management of non-communicable diseases and injury at the primary care level, specifically including nutritional intervention for cardiovascular diseases and metabolic disorders, strengthening primary health care system to improve quality of care, integrated care approach for the growing burden of multimorbidity and unintentional injury prevention. He was selected as the “Emerging Leader” by World Heart Federation in 2018 and awarded as the Fogarty Global Health Fellow by Fogarty International Center of NIH in the US. Over the past five years, Professor Tian published widely as corresponding author or senior author, including publications in The New England Journal of Medicine, JAMA, JAMA Cardiology, Circulation and The Lancet Public Health.

Eloise Todd is the Executive Director and Founder of rani, which coordinates advocacy to build societal resilience to shifts, change, and crisis. An advocacy, policy, campaigns, and strategy specialist, Eloise has over 25 years’ experience working to change policies, legislation and budgets to improve lives. Primarily, she has worked in international development and global health, including as a political adviser within the EU institutions and as Global Policy Director of the ONE Campaign. Eloise campaigned against the U.K.’s Brexit deal, building one of the largest pro-European organisations into a national campaign force. Eloise co-founded Pandemic Action Network with three colleagues in April 2020 and took on the Executive Director role in August 2022 and led the evolution to become rani (Resilience Action Network International) in November 2025. In 2023, Eloise helped launch Resilience Action Network Africa (RANA).

Eloise has worked throughout her 25-year career to change policies, legislation, and budgets to improve lives. She has served as a political adviser in the European Parliament, led global policy at the ONE campaign, establishing their EU office. As a social impact innovator, Eloise also built one of the largest pro-European organizations in the UK, Best for Britain. Eloise is a trustee of the Jo Cox Foundation and also advises several not-for-profit campaigns on a voluntary basis.

‍

Professor Jose M. Valderas is Primary Care Physician with a commitment to research that is relevant for decision making in clinical practice and health policy. He is Professor of Medicine and Director of the Centre for Research in Health Systems Performance at the National University of Singapore, and Head of the Department of Family Medicine of the National University Health System. 

Professor Jose M. Valderas’s research interests focus on the use of patient reports on their health and care (PROMs and PREMs) for health policy decision-making and clinical practice, and the evaluation and improvement of quality, safety, and outcomes of Primary Care. He is particularly interested in models of care that meet the needs of patients with multimorbidity. He is Field Chief Editor for Frontiers in Health Services. He is a Lancet Commissioner for Pandemic Readiness, Implementation, Monitoring and Evaluation (PRIME) and for Primary Health Care Transformation. 

He has provided expert advice to the World Health Organization (WHO) on the WHO/UNICEF Declaration of Astana for Primary Health Care and linked initiatives and projects, and on health systems strengthening; the Organisation for Economic Co-operation & Development (OECD) and the Welcome Trust on patient reported quality indicators; and NHS England on the Quality and Outcomes Framework (QOF) and patient reported outcomes. He is a Fellow of the Academy of Medicine of Singapore (FAMS). He has been elected by my peers to serve as Chair of the Working Party on Quality & Safety, WONCA since 2021 and as President of the International Society for Quality of Life Research (2017-2019).

Dr. Joyce Wamoyi is a Social and Behavioural researcher with over 20 years of experience in adolescent and young people’s  Sexual and Reproductive Health (SRH); Social determinants of health; Structural drivers of risk; qualitative research; Parenting and child outcomes; and Sexual and gender-based violence. She has contributed to the understanding dynamics of risky sexual behaviour and to the development of measures to capture complexity of risky sexual behaviour.  She is the Tanzanian lead Principal Investigator for the Parenting for Lifelong Health digital parenting programmes (ParentApp-Teens and ParentApp-Kids) to prevent violence against children. Dr. Wamoyi has excelled in translating complex research findings into actionable strategies, collaborating with national governments, civil society organizations, bilateral and philanthropic donors, and UN agencies. She is the lead of the project on Building a national parenting support system for scaling evidence-based parenting interventions in Tanzania. She was a member of the: WHO Behavioural Insights Technical Advisory Group; and UNICEF Advisory Board for the multi-country project “Children’s Experiences and Perspectives of Covid-19, and restrictions. She is a co-funder of the organisation, REAL Transformation that collects evidence and transforms it into action.

Clare Wenham is an Associate Professor of Global Health Policy at the London School of Economics (LSE) and an academic expert in global health security, global health governance, and global health policy. She holds a PhD in International Relations.

Her research examines how state and non-state actors prepare for and respond to epidemics, the political challenges within the global health architecture, and the wider social and economic effects of policies introduced during health emergencies.

Her work spans three main areas: global health security, focusing on infectious disease preparedness and response, pandemic financing, the pandemic treaty, health security and universal health coverage, disease surveillance, and the risks of over-securitising health; global health governance, examining the roles and interactions of organisations such as WHO, governments, private-sector actors, and other stakeholders; and gender and global health, exploring how health and epidemic policies can have different impacts on women and marginalised groups, including effects on economic participation and access to sexual and reproductive health services. Her empirical research includes case studies from Brazil, Panama, Cuba, Thailand, the UK, and Latin America, as well as research on Zika and COVID-19

‍